EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Chimeric Ribonuclease A Inhibitor for Molecular Biology Applications: SUMO Fusion as an Engineering Strategy

Dmitry Sukhov iD, Tatyana Petrova, Daria Kruglova, Inna Kholoshenko, German Romanenko iD, Yuri Utkin iD, Pavel Pantyushenko iD, Dmitry Trofimov, Vladimir Korotkiy iD, Ekaterina Barsova, Yulia Kirillova

Current Issues in Molecular Biology · 18.06.2026 · 48 (6) · 637

DOI: 10.3390/cimb48060637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.06.2026. Verfasst von Dmitry Sukhov und 10 weiteren Autor:innen. Beteiligte Einrichtung: DNA-Technology LLC, 117587 Moscow, Russia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DNA-Technology LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A chimeric RNase A inhibitor (SUMO-RI) was produced by fusing a SUMO domain to the N-terminus of the murine Rnh1 protein. Functional assays demonstrated that SUMO-RI effectively protects RNA from RNase A-mediated degradation under conditions mimicking real-time RT-PCR, with performance comparable to that of commercial RNase inhibitors. The primary advantage of the chimeric design is its improved technological suitability: SUMO-RI exhibits markedly enhanced storage stability relative to the recombinant Rnh1 inhibitor. However, this benefit comes with a trade-off—SUMO fusion reduces thermostability at temperatures above approximately 47 °C. Together, these findings establish SUMO fusion as a rational engineering strategy for RNase inhibitors, offering improved practical handling at the expense of thermal resilience.

Schlagwörter

Stichwörter der Autor:innen

RNA stabilityRNase inhibitorRT-qPCRSUMO fusionchimeric proteinprotein engineeringprotein–protein interaction

Autor:innen und Institutionen

  • DNA-Technology LLC, 117587 Moscow, Russia.
  • M.V. Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.
  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
  • Department of Molecular Technologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

ORCID-Profile: Dmitry Sukhov, German Romanenko, Yuri Utkin, Pavel Pantyushenko, Vladimir Korotkiy

Förderung

  • DNA-Technology LLC

Zitieren

APA

Sukhov, D., Petrova, T., Kruglova, D., Kholoshenko, I., Romanenko, G., Utkin, Y., Pantyushenko, P., Trofimov, D., Korotkiy, V., Barsova, E., & Kirillova, Y. (2026). Development of Chimeric Ribonuclease A Inhibitor for Molecular Biology Applications: SUMO Fusion as an Engineering Strategy. Current Issues in Molecular Biology, 48(6), 637. https://doi.org/10.3390/cimb48060637

Vancouver

Sukhov D, Petrova T, Kruglova D, Kholoshenko I, Romanenko G, Utkin Y, et al. Development of Chimeric Ribonuclease A Inhibitor for Molecular Biology Applications: SUMO Fusion as an Engineering Strategy. Current Issues in Molecular Biology. 2026;48(6):637. doi:10.3390/cimb48060637

BibTeX
@article{Sukhov2026,
  author = {Sukhov, Dmitry and Petrova, Tatyana and Kruglova, Daria and Kholoshenko, Inna and Romanenko, German and Utkin, Yuri and Pantyushenko, Pavel and Trofimov, Dmitry and Korotkiy, Vladimir and Barsova, Ekaterina and Kirillova, Yulia},
  title = {Development of Chimeric Ribonuclease A Inhibitor for Molecular Biology Applications: SUMO Fusion as an Engineering Strategy},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {6},
  pages = {637},
  doi = {10.3390/cimb48060637}
}
Kostenlos starten →